Abstract
Objective
Vein of Galen malformation (VGM) is a rare cerebrovascular malformation. Children with VGM presenting in newborn period demonstrate various clinical courses from normal development to severe neurologic impairment or death. The aim of our study was to describe the characteristics of pulmonary hypertension and its treatment response in newborn infants with VGM.
Methods
We retrospectively reviewed medical records of newborn infants with VGM who were antenatal diagnosed and treated with endovascular embolization in a single tertiary center. Clinical characteristics including echocardiographic data were described.
Results
A total of six patients were diagnosed with VGM. Endovascular embolization was performed early postnatal days (median, 6.5 days) in four patients who required cardiorespiratory support. Echocardiography revealed pulmonary hypertension in the four cases and two of them received targeted therapy against pulmonary hypertension including inhaled nitric oxide and other pulmonary vasodilators. Incomplete occlusion of VGM failed to reverse the pulmonary hypertension. Mortality occurred in two patients with severe pulmonary hypertension in whom incomplete occlusion for VGM lesion. The cause of death was multi-organ failure secondary to right heart failure.
References
1. Mortazavi MM, Griessenauer CJ, Foreman P, Bavarsad Shahripour R, Shoja MM, Rozzelle CJ, et al. Vein of Galen aneurysmal malformations: critical analysis of the literature with proposal of a new classification system. J Neurosurg Pediatr. 2013; 12:293–306.
2. Kim DJ, Suh DC, Kim BM, Kim DI. Adjuvant coil assisted glue embolization of vein of Galen aneurysmal malformation in pediatric patients. Neurointervention. 2018; 13:41–7.
3. Fullerton HJ, Aminoff AR, Ferriero DM, Gupta N, Dowd CF. Neurodevelopmental outcome after endovascular treatment of vein of Galen malformations. Neurology. 2003; 61:1386–90.
4. Lylyk P, Viñuela F, Dion JE, Duckwiler G, Guglielmi G, Peacock W, et al. Therapeutic alternatives for vein of Galen vascular malformations. J Neurosurg. 1993; 78:438–45.
5. Mitchell PJ, Rosenfeld JV, Dargaville P, Loughnan P, Ditchfield MR, Frawley G, et al. Endovascular management of vein of Galen aneurysmal malformations presenting in the neonatal period. AJNR Am J Neuroradiol. 2001; 22:1403–9.
6. Lasjaunias PL, Chng SM, Sachet M, Alvarez H, Rodesch G, Garcia-Monaco R. The management of vein of Galen aneurysmal malformations. Neurosurgery. 2006; 59(5 Suppl 3):S184–94. discussion S3–13.
7. Schneider SJ, Wisoff JS, Epstein FJ. Complications of ventriculoperitoneal shunt procedures or hydrocephalus associated with vein of Galen malformations in childhood. Neurosurgery. 1992; 30:706–8.
8. Meyers PM, Halbach VV, Phatouros CP, Dowd CF, Malek AM, Lempert TE, et al. Hemorrhagic complications in vein of Galen malformations. Ann Neurol. 2000; 47:748–55.
9. Gailloud P, O'Riordan DP, Burger I, Levrier O, Jallo G, Tamargo RJ, et al. Diagnosis and management of vein of galen aneurysmal malformations. J Perinatol. 2005; 25:542–51.
10. Chevret L, Durand P, Alvarez H, Lambert V, Caeymax L, Rodesch G, et al. Severe cardiac failure in newborns with VGAM. Prognosis significance of hemodynamic parameters in neonates presenting with severe heart failure owing to vein of Galen arteriovenous malformation. Intensive Care Med. 2002; 28:1126–30.
11. McSweeney N, Brew S, Bhate S, Cox T, Roebuck DJ, Ganesan V. Management and outcome of vein of Galen malformation. Arch Dis Child. 2010; 95:903–9.
12. Heuer GG, Gabel B, Beslow LA, Stiefel MF, Schwartz ES, Storm PB, et al. Diagnosis and treatment of vein of Galen aneurysmal malformations. Childs Nerv Syst. 2010; 26:879–87.
13. Levin DL, Heymann MA, Kitterman JA, Gregory GA, Phibbs RH, Rudolph AM. Persistent pulmonary hypertension of the newborn infant. J Pediatr. 1976; 89:626–30.
14. Jones BV, Ball WS, Tomsick TA, Millard J, Crone KR. Vein of Galen aneurysmal malformation: diagnosis and treatment of 13 children with extended clinical follow-up. AJNR Am J Neuroradiol. 2002; 23:1717–24.
15. Halbach VV, Dowd CF, Higashida RT, Balousek PA, Ciricillo SF, Edwards MS. Endovascular treatment of mural-type vein of Galen malformations. J Neurosurg. 1998; 89:74–80.
16. Lasjaunias P, Rodesch G, Pruvost P, Laroche FG, Landrieu P. Treatment of vein of Galen aneurysmal malformation. J Neurosurg. 1989; 70:746–50.
17. Cherif A, Néji K, Sebaï L, Ben Jemaa W, Bellagua I, Jebnoun S, et al. Vein of Galen aneurysmal malformation: a neonatal case with unusual evolution. Arch Pediatr. 2007; 14:893–6.
18. Frawley GP, Dargaville PA, Mitchell PJ, Tress BM, Loughnan P. Clinical course and medical management of neonates with severe cardiac failure related to vein of Galen malformation. Arch Dis Child Fetal Neonatal Ed. 2002; 87:F144–9.
19. Gupta AK, Rao VR, Varma DR, Kapilamoorthy TR, Kesavadas C, Krishna-moorthy T, et al. Evaluation, management, and long-term follow up of vein of Galen malformations. J Neurosurg. 2006; 105:26–33.
20. Pellegrino PA, Milanesi O, Saia OS, Carollo C. Congestive heart failure secondary to cerebral arteriovenous fistula. Childs Nerv Syst. 1987; 3:141–4.
21. Tiwary S, Geethanath RM, Abu-Harb M. Vein of Galen malformation presenting as persistent pulmonary hypertension of newborn (PPHN). BMJ Case Rep. 2013; 2013:bcr2013200425.
22. Dahdah NS, Alesseh H, Dahms B, Saker F. Severe pulmonary hypertensive vascular disease in two newborns with aneurysmal vein of galen. Pediatr Cardiol. 2001; 22:538–41.
23. Reddy VM, Meyrick B, Wong J, Khoor A, Liddicoat JR, Hanley FL, et al. In utero placement of aortopulmonary shunts. A model of postnatal pulmonary hypertension with increased pulmonary blood flow in lambs. Circulation. 1995; 92:606–13.
Table 1.
Yasargil classification of clinical outcome 5-point scale14 (score of 0: death; score of 1: severe neurological impairment; score of 2: moderate neurological impairment; score of 3: mild neurological impairment; score of 4: normal).
Abbreviations: No., number; GA, gestational age; F, female; Y, yes; IVH, intraventricular hemorrhage; NA, not applicable; N, no; HDC, hydrocephalus; M, male.